ICSC 0117 - CADMIUM OXIDE

« back to the search result list

CADMIUM OXIDE	ICSC: 0117 (October 2005)
Cadmium monoxide

CAS #: 1306-19-0

UN #: 2570 (Cadmium compounds)

EC Number: 215-146-2

	ACUTE HAZARDS	PREVENTION	FIRE FIGHTING
FIRE & EXPLOSION	Not combustible. Gives off irritating or toxic fumes (or gases) in a fire.		In case of fire in the surroundings, use appropriate extinguishing media.

PREVENT DISPERSION OF DUST! AVOID ALL CONTACT! IN ALL CASES CONSULT A DOCTOR!
	SYMPTOMS	PREVENTION	FIRST AID
Inhalation	Cough. Laboured breathing. Shortness of breath. Symptoms may be delayed. See Notes.	Use local exhaust or breathing protection.	Fresh air, rest. Half-upright position. Refer for medical attention.
Skin			Rinse skin with plenty of water or shower.
Eyes	Redness. Pain.	Wear safety goggles or eye protection in combination with breathing protection if powder.	First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then refer for medical attention.
Ingestion	Abdominal cramps. Diarrhoea. Nausea. Vomiting.	Do not eat, drink, or smoke during work. Wash hands before eating.	Rinse mouth. Refer for medical attention .

SPILLAGE DISPOSAL	CLASSIFICATION & LABELLING
Personal protection: particulate filter respirator adapted to the airborne concentration of the substance. Do NOT let this chemical enter the environment. Vacuum spilled material with specialist equipment. If appropriate, moisten first to prevent dusting. Carefully collect remainder. Then store and dispose of according to local regulations.	According to UN GHS Criteria Transportation UN Classification UN Hazard Class: 6.1; UN Pack Group: III
STORAGE
Separated from food and feedstuffs. Store in an area without drain or sewer access.
PACKAGING
Unbreakable packaging. Put breakable packaging into closed unbreakable container. Do not transport with food and feedstuffs. Severe marine pollutant.

CADMIUM OXIDE

ICSC: 0117

PHYSICAL & CHEMICAL INFORMATION
Physical State; Appearance ODOURLESS BROWN CRYSTALS OR AMORPHOUS POWDER. Physical dangers Chemical dangers Reacts violently with magnesium when heated. This generates fire and explosion hazard.	Formula: CdO Molecular mass: 128.4 Sublimation point: 1559°C (crystals) Decomposes at 900-1000°C (amorphous) Density (amorphous): 6.9 g/cm³ Density (crystals): 8.15 g/cm³ Solubility in water: none

PHYSICAL & CHEMICAL INFORMATION

Physical State; Appearance
ODOURLESS BROWN CRYSTALS OR AMORPHOUS POWDER.

Physical dangers

Chemical dangers
Reacts violently with magnesium when heated. This generates fire and explosion hazard.

Formula: CdO
Molecular mass: 128.4
Sublimation point: 1559°C (crystals)
Decomposes at 900-1000°C (amorphous)
Density (amorphous): 6.9 g/cm³
Density (crystals): 8.15 g/cm³
Solubility in water: none

EXPOSURE & HEALTH EFFECTS
Routes of exposure The substance can be absorbed into the body by inhalation of its aerosol and by ingestion. Effects of short-term exposure The substance is irritating to the respiratory tract. May cause mechanical irritation to the eyes. Inhalation of the aerosol may cause lung oedema. See Notes. Exposure far above the OEL could cause death. The effects may be delayed. Medical observation is indicated.	Inhalation risk A harmful concentration of airborne particles can be reached quickly when dispersed. Effects of long-term or repeated exposure The substance may have effects on the kidneys and lungs. This may result in kidney impairment and tissue lesions. This substance is carcinogenic to humans.

EXPOSURE & HEALTH EFFECTS

Routes of exposure
The substance can be absorbed into the body by inhalation of its aerosol and by ingestion.

Effects of short-term exposure
The substance is irritating to the respiratory tract. May cause mechanical irritation to the eyes. Inhalation of the aerosol may cause lung oedema. See Notes. Exposure far above the OEL could cause death. The effects may be delayed. Medical observation is indicated.

Inhalation risk
A harmful concentration of airborne particles can be reached quickly when dispersed.

Effects of long-term or repeated exposure
The substance may have effects on the kidneys and lungs. This may result in kidney impairment and tissue lesions. This substance is carcinogenic to humans.

OCCUPATIONAL EXPOSURE LIMITS
TLV: (respirable fraction): 0.002 mg/m³, as TWA; 0.01 mg/m³, as TWA; A2 (suspected human carcinogen); BEI issued. MAK: (as Cd, inhalable fraction): skin absorption (H); carcinogen category: 1; germ cell mutagen group: 3A. EU-OEL: inhalable 0.001 mg/m³ as TWA; (see Notes)

ENVIRONMENT
Bioaccumulation of this chemical may occur in plants and seafood. It is strongly advised not to let the chemical enter into the environment.

NOTES
Depending on the degree of exposure, periodic medical examination is suggested. The symptoms of lung oedema often do not become manifest until a few hours have passed and they are aggravated by physical effort. Rest and medical observation are therefore essential. Immediate administration of an appropriate inhalation therapy by a doctor, or by an authorized person, should be considered. Do NOT take working clothes home. An EU-OEL of 0.004 mg/m³ is allowed until 11 July 2027.

NOTES

Depending on the degree of exposure, periodic medical examination is suggested.
The symptoms of lung oedema often do not become manifest until a few hours have passed and they are aggravated by physical effort. Rest and medical observation are therefore essential.
Immediate administration of an appropriate inhalation therapy by a doctor, or by an authorized person, should be considered.
Do NOT take working clothes home.
An EU-OEL of 0.004 mg/m³ is allowed until 11 July 2027.

ADDITIONAL INFORMATION

EC Classification
Symbol: T+, N; R: 45-26-48/23/25-62-63-68-50/53; S: 53-45-60-61; Note: E

All rights reserved. The published material is being distributed without warranty of any kind, either expressed or implied. Neither ILO nor WHO nor the European Commission shall be responsible for the interpretation and use of the information contained in this material.